Earnings History Data for Ultragenyx Pharmaceutical Inc. (RARE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. is involved in the identification, acquisition, development and commercialization of products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. The Company's product pipeline include KRN23 (UX023) for the treatment of XLH, rhGUS (UX003) for the treatment of MPS 7, rhPPCA (UX004) for the treatment of galactosialidosis, Triheptanoin (UX007) for the treatment of LC-FAOD, Triheptanoin (UX007) for the treatment of Glut1 DS and SA-ER (UX001) for the treatment of HIBM which are in different clinical phases. Ultragenyx Pharmaceutical Inc. is headquartered in Novato, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-11-2024	AH		RARE	Ultragenyx Pharmaceutical Inc.	4,700	-1.40	-1.45	-2.23	Ultragenyx Pharmaceutical GAAP EPS of -$1.40 beats by $0.08, revenue of $139.45M beats by $4.2M [11/5/2024 4:12 PM]	50.48	-1.70 (-3.26%)	52.50	0.32 (0.61%)	34.06 - 60.37	1,368,825	920,000	390
Ultragenyx Pharmaceutical GAAP EPS of -$1.40 beats by $0.08, revenue of $139.45M beats by $4.2M [11/5/2024 4:12 PM] Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update [2024-11-05 04:01PM] Ultragenyx Pharmaceutical Inc (RARE) Q3 2024 Earnings Call Highlights: Robust Revenue Growth ... [2024-11-06 02:27AM] Ultragenyx: Q3 Earnings Snapshot [Nov-05-24 04:11PM]
01-08-2024	AH		RARE	Ultragenyx Pharmaceutical Inc.	3,720	-1.52	-1.64	-2.25	Ultragenyx Pharmaceutical GAAP EPS of -$1.52 beats by $0.13, revenue of $147.02M beats by $23.81M [8/1/2024 4:23 PM]	50.58	6.43 (14.56%)	44.59	0.44 (1.00%)	31.52 - 54.56	2,362,137	660,000	20,612
Ultragenyx Pharmaceutical GAAP EPS of -$1.52 beats by $0.13, revenue of $147.02M beats by $23.81M [8/1/2024 4:23 PM]
02-05-2024	AH		RARE	Ultragenyx Pharmaceutical Inc.	3,620	-2.03	-1.72	-2.33	Ultragenyx Pharmaceutical GAAP EPS of -$2.03 misses by $0.28, revenue of $108.8M misses by $7.64M [5/2/2024 4:02 PM]	42.75	-0.45 (-1.04%)	41.37	-1.83 (-4.24%)	31.52 - 54.98	984,001	750,000	2,841
Ultragenyx Pharmaceutical GAAP EPS of -$2.03 misses by $0.28, revenue of $108.8M misses by $7.64M [5/2/2024 4:02 PM]
15-02-2024	AH		RARE	Ultragenyx Pharmaceutical Inc.	3,610	-1.52	-1.65	-2.16	Ultragenyx Pharmaceutical GAAP EPS of -$1.52 beats by $0.10, revenue of $127.39M beats by $5.34M [2/15/2024 4:02 PM]	48.94	2.68 (5.79%)	46.26	0.0 (0.00%)	31.52 - 54.98	900,994	630,000	21,814
Ultragenyx Pharmaceutical GAAP EPS of -$1.52 beats by $0.10, revenue of $127.39M beats by $5.34M [2/15/2024 4:02 PM]
02-11-2023	AH		RARE	Ultragenyx Pharmaceutical Inc.	2,530	-2.23	-2.08	-2.43	Ultragenyx Pharmaceutical GAAP EPS of -$2.23 misses by $0.12, revenue of $98.1M misses by $4.78M [11/2/2023 5:01 PM]	38.84	2.24 (6.12%)	36.41	-0.19 (-0.52%)	31.52 - 54.98	1,037,091	1,150,000	9,161
Ultragenyx Pharmaceutical GAAP EPS of -$2.23 misses by $0.12, revenue of $98.1M misses by $4.78M [11/2/2023 5:01 PM]
03-08-2023	AH		RARE	Ultragenyx Pharmaceutical Inc.	3,040	-2.25	-2.11	-2.26	Ultragenyx Pharmaceutical GAAP EPS of -$2.25 misses by $0.15, revenue of $108.3M beats by $3.31M [8/3/2023 4:52 PM]	37.60	-3.70 (-8.96%)	42.11	0.81 (1.96%)	33.36 - 56.42	1,394,545	430,000	7,548
Ultragenyx Pharmaceutical GAAP EPS of -$2.25 misses by $0.15, revenue of $108.3M beats by $3.31M [8/3/2023 4:52 PM]
04-05-2023	AH	4:05 PM ET (May 4)	RARE	Ultragenyx Pharmaceutical Inc.	3,000	-2.33	-1.97	-2.19	Ultragenyx Pharmaceutical GAAP EPS of -$2.33 misses by $0.33, revenue of $100.5M misses by $3.4M [5/4/2023 4:49 PM]	47.26	1.45 (3.15%)	45.00	-0.81 (-1.77%)	33.36 - 70.66	1,091,612	620,000	220
Ultragenyx Pharmaceutical GAAP EPS of -$2.33 misses by $0.33, revenue of $100.5M misses by $3.4M [5/4/2023 4:49 PM]
16-02-2023	AH	4:05 PM ET (Feb 16)	RARE	Ultragenyx Pharmaceutical Inc.	3,030	-2.16	-2.03	-1.79	Ultragenyx Pharmaceutical GAAP EPS of -$2.16 beats by $0.02, revenue of $103.35M misses by $1.76M [2/16/2023 4:13 PM]	48.69	4.42 (9.98%)	43.00	-1.27 (-2.87%)	33.36 - 85.53	628,923	490,000	14,302
Ultragenyx Pharmaceutical GAAP EPS of -$2.16 beats by $0.02, revenue of $103.35M misses by $1.76M [2/16/2023 4:13 PM]
02-11-2022	AH	4:00 PM ET (Nov 2)	RARE	Ultragenyx Pharmaceutical Inc.	2,830	-2.43	-2.29	-1.08	Ultragenyx Pharmaceutical GAAP EPS of -$3.50 misses by $1.66, revenue of $90.7M misses by $5M [11/2/2022 4:49 PM]	38.20	-2.39 (-5.89%)	40.50	-0.09 (-0.22%)	36.67 - 89.56	553,135	650,000	6,610
Ultragenyx Pharmaceutical GAAP EPS of -$3.50 misses by $1.66, revenue of $90.7M misses by $5M [11/2/2022 4:49 PM] Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update [Nov-02-22 04:05PM]
28-07-2022	AH	4:05 PM ET (Jul 28)	RARE	Ultragenyx Pharmaceutical	3,562	-2.26	-1.72	0.00	Ultragenyx Pharmaceutical GAAP EPS of -$2.26 misses by $0.49, revenue of $89.34M beats by $2.01M [7/28/2022 4:21 PM]	53.32	1.44 (2.78%)	51.88	0.0 (0.00%)	45.20 - 104.38	730,447	1,130,000	8,968
Ultragenyx Pharmaceutical GAAP EPS of -$2.26 misses by $0.49, revenue of $89.34M beats by $2.01M [7/28/2022 4:21 PM] Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update [Jul-28-22 04:01PM]
05-05-2022	AH	4:05 PM ET (May 5)	RARE	Ultragenyx Pharmaceutical Inc.	5,020	-2.19	-1.76	-2.03	Ultragenyx Pharmaceutical GAAP EPS of -$2.19 misses by $0.41, revenue of $79.9M misses by $4.35M [5/5/2022 4:15 PM]	57.54	-8.89 (-13.38%)	57.54	0.0 (0.00%)	56.59 - 119.54	964,631	370,000	1,578
Ultragenyx Pharmaceutical GAAP EPS of -$2.19 misses by $0.41, revenue of $79.9M misses by $4.35M [5/5/2022 4:15 PM] Ultragenyx Pharmaceutical's price target lowered by Cowen analyst, rating maintained [5/6/2022 12:37 PM] Ultragenyx Reports First Quarter 2022 Financial Results and Corporate Update [May-05-22 04:05PM] Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates [May-05-22 05:25PM] Ultragenyx's (RARE) Q1 Earnings & Revenues Miss Estimates [May-06-22 11:37AM]
10-02-2022	AH	4:05 PM ET (Feb 10)	RARE	Ultragenyx Pharmaceutical Inc.	4,710	-1.79	-1.32	-1.34	Ultragenyx Pharmaceutical GAAP EPS of -$1.79 misses by $0.44, revenue of $83.4M misses by $0.28M [2/10/2022 4:24 PM]	72.85	1.45 (2.03%)	71.40	0.0 (0.00%)	62.37 - 171.51	916,263	390,000	10,334
Ultragenyx Pharmaceutical GAAP EPS of -$1.79 misses by $0.44, revenue of $83.4M misses by $0.28M [2/10/2022 4:24 PM] Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update [Feb-10-22 04:05PM] Ultragenyx (RARE) Reports Q4 Loss, Lags Revenue Estimates [Feb-10-22 05:25PM] Ultragenyx's (RARE) Q4 Earnings & Revenues Miss Estimates [Feb-11-22 12:02PM]
02-11-2021	AH	4:05 PM ET (Nov 2)	RARE	Ultragenyx Pharmaceutical Inc.	5,750	-1.08	-1.43	-1.13	Ultragenyx Pharmaceutical EPS beats by $0.34, beats on revenue [11/2/2021 4:17 PM]	86.57	1.74 (2.05%)	84.83	0.0 (0.00%)	75.83 - 179.65	643,137	430,000	5,854
Ultragenyx Pharmaceutical EPS beats by $0.34, beats on revenue [11/2/2021 4:17 PM] Ultragenyx Reports Third Quarter 2021 Financial Results and Corporate Update [Nov-02-21 04:05PM] Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-21 05:25PM] Ultragenyx Pharmaceutical inc (RARE) Q3 2021 Earnings Call Transcript [Nov-03-21 12:01AM] Ultragenyx's (RARE) Q3 Earnings & Revenues Beat Estimates [Nov-03-21 11:56AM]
02-08-2021	AH	4:00 PM ET (Aug 2)	RARE	Ultragenyx Pharmaceutical Inc.	5,420	-1.45	-1.28	-0.82	Ultragenyx Pharmaceutical EPS misses by $0.54, beats on revenue [8/2/2021 4:09 PM]	83.70	2.86 (3.54%)	79.52	-1.32 (-1.63%)	72.83 - 179.65	659,421	350,000	1,294
Ultragenyx Pharmaceutical EPS misses by $0.54, beats on revenue [8/2/2021 4:09 PM] Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update [Aug-02-21 04:05PM] Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates [Aug-02-21 05:35PM] Ultragenyx Pharmaceutical inc (RARE) Q2 2021 Earnings Call Transcript [Aug-03-21 08:30AM] Ultragenyx (RARE) Q2 Loss Widens Y/Y, Revenues Beat Estimates [Aug-03-21 01:22PM]
04-05-2021	AH	4:05 PM ET (May 4)	RARE	Ultragenyx Pharmaceutical Inc.	7,600	-2.03	-1.25	-2.04	Ultragenyx Pharmaceutical EPS misses by $0.79, beats on revenue [5/4/2021 4:36 PM]	106.01	4.16 (4.08%)	106.01	0.0 (0.00%)	61.96 - 179.65	377,931	370,000	8,535
Ultragenyx Pharmaceutical EPS misses by $0.79, beats on revenue [5/4/2021 4:36 PM] Esperion sinks after Stifel downgrade, Community Health adds another bull; in today’s healthcare analyst action [5/5/2021 9:01 AM] Ultragenyx Pharmaceutical, Inc. to Host Earnings Call [May-04-21 03:15PM] Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update [May-04-21 04:01PM] Ultragenyx (RARE) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 05:35PM] Ultragenyx Pharmaceutical Inc (RARE) Q1 2021 Earnings Call Transcript [May-05-21 06:01AM] Ultragenyx (RARE) Q1 Loss Narrows Y/Y, Revenues Beat Estimates [May-05-21 07:52AM]
11-02-2021	AH	4:05 PM ET (Feb 11)	RARE	Ultragenyx Pharmaceutical Inc.	10,970	-1.34	-1.06	-1.64	Ultragenyx Pharmaceutical EPS beats by $0.79, beats on revenue [2/11/2021 4:36 PM]	150.38	-12.40 (-7.62%)	162.78	0.0 (0.00%)	31.99 - 179.65	616,991	353,791	33,331
Ultragenyx Pharmaceutical EPS beats by $0.79, beats on revenue [2/11/2021 4:36 PM] Ultragenyx faces downgrade at JPM despite earnings beat [2/12/2021 8:39 AM] Ultragenyx (RARE) Q4 Loss Narrows Y/Y, Revenues Beat Estimates [Feb-12-21 10:09AM] Ultragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates [Feb-11-21 05:45PM]
27-10-2020	AH	4:00 PM ET (Oct 27)	RARE	Ultragenyx Pharmaceutical Inc.	5,640	-1.13	-1.28	-1.96	Ultragenyx Pharmaceutical EPS beats by $0.15, beats on revenue [10/27/2020 4:23 PM]	95.30	-2.14 (-2.20%)	95.00	-2.44 (-2.50%)	31.99 - 100.00	528,605	348,736	6,363

30-07-2020	AH	4:00 PM ET (Jul 30)	RARE	Ultragenyx Pharmaceutical Inc.	4,590	-0.82	-1.56	-1.72	Ultragenyx Pharmaceutical EPS beats by $1.94, beats on revenue [7/30/2020 4:30 PM]	77.83	0.23 (0.30%)	77.60	0.0 (0.00%)	31.99 - 91.77	261,849	374,625	4,930

06-05-2020	AH		RARE	Ultragenyx Pharmaceutical Inc.	3,860	-2.04	-1.60	-1.82		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0